HemaSphere (Jun 2022)

P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

  • D. Duarte,
  • S. Duarte,
  • C. Sol dos Reis,
  • P. Silva Coelho,
  • L. Leite,
  • R. Branca,
  • S. Roncon,
  • C. Pinho Vaz,
  • A. Campos

DOI
https://doi.org/10.1097/01.HS9.0000848208.53297.5e
Journal volume & issue
Vol. 6
pp. 1221 – 1222

Abstract

Read online

No abstracts available.